Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Temporary Suspension

3 Jul 2023 07:00

RNS Number : 6557E
Science in Sport PLC
03 July 2023
 

3 July 2023

Science in Sport plc

("Science in Sport", "the Company" or the "Group")

 

Temporary Suspension

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, announces that it has not been able to publish its audited financial statements for the year ended 31 December 2022 by the six month deadline as final sign off from the auditors is still outstanding.

Consequently, the Company's ordinary shares will be suspended from trading on AIM with effect from 8.00 a.m. on 3 July 2023. The suspension will remain in place until the Company's audited financial statements for the year ended 31 December 2022 have been published, which is expected to be imminently.

 

For further information please contact:

For further information:

Science in Sport plc

T: 020 7400 3700

Stephen Moon, CEO

Daniel Lampard, CFO

 

Liberum (Nominated Adviser and Broker)

T: 020 3100 2000

Richard Lindley

William Hall

Lucas Bamber

 

 

Notes to Editors

About Science in Sport plc

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, sports nutrition market, worth $24.6bn in 2022 and forecast to grow CAGR 5.9% from 2022 to 2027.1

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading endurance and strength athlete Ross Edgley and influencer Gabby Allen. 

SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA. 

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs, as well as Official Nutrition Partner to the Milwaukee Bucks, 2021 National Basketball Association Champions. 

For further information, please visit phd.com and scienceinsport.com

 

Euromonitor Passport Database Global Assessment (October 2022)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SRSUURAROUUBRUR
Date   Source Headline
15th Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSPre-Close Trading Update
4th Jan 20217:00 amRNSDates for Investor Presentation and Trading Update
4th Dec 20208:52 amRNSNotification of Major Holdings
3rd Dec 202012:16 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSTrading Update
19th Nov 20207:00 amRNSIntroduction of Recyclable Packaging Range
17th Nov 202011:52 amRNSNotification of Major Holdings
3rd Nov 20204:17 pmRNSHolding(s) in Company
5th Oct 20207:00 amRNSPDMR Share Purchases
1st Oct 20207:00 amRNSGrant of Options
21st Sep 20202:05 pmRNSSecond Price Monitoring Extn
21st Sep 20202:00 pmRNSPrice Monitoring Extension
21st Sep 202011:06 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
21st Sep 20209:05 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
16th Sep 20207:00 amRNSInterim Results
10th Sep 20204:39 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSInvestor Presentation
9th Jul 20207:00 amRNSHalf Year Trading Update
30th Jun 20203:32 pmRNSNotification of Major Holdings
25th Jun 20205:03 pmRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
2nd Jun 20207:00 amRNSNotice of AGM
21st May 20207:00 amRNSNew Debt Financing Facility
28th Apr 20206:02 pmRNSNotification of Major Holdings
28th Apr 20204:11 pmRNSNotification of Major Holdings
28th Apr 20201:21 pmRNSNotification of Major Holdings
24th Apr 20204:22 pmRNSNotification of Major Holdings
24th Apr 20202:41 pmRNSNotification of Major Holdings
23rd Apr 20207:50 amRNSResult of Placing and Director/PDMR Dealings
22nd Apr 20204:51 pmRNSProposed Placing of New Ordinary Shares
17th Apr 202012:05 pmRNSAnnual Report & Accounts
18th Mar 20207:00 amRNSFinal Results
11th Mar 20205:34 pmRNSNotification of Major Holdings
31st Jan 20207:00 amRNSAppointment of Non-Executive Director
23rd Jan 202010:20 amRNSNotification of Major Holdings
17th Jan 202012:33 pmRNSNotification of Major Holdings
15th Jan 20204:18 pmRNSPDMR Dealing
14th Jan 20207:00 amRNSPre-Close Trading Update
22nd Nov 20197:00 amRNSTrading Update
5th Nov 20197:00 amRNSAppointment of Group Supply Chain Director
29th Oct 20197:00 amRNSAppointment of Group E-Commerce Director
1st Oct 20197:00 amRNSDirectorate Change
27th Sep 20193:58 pmRNSNotification of Major Holdings
24th Sep 20193:32 pmRNSPDMR Dealings - Exercise of Option Shares
18th Sep 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.